1346 related articles for article (PubMed ID: 28290206)
1. Diverse Applications of Nanomedicine.
Pelaz B; Alexiou C; Alvarez-Puebla RA; Alves F; Andrews AM; Ashraf S; Balogh LP; Ballerini L; Bestetti A; Brendel C; Bosi S; Carril M; Chan WC; Chen C; Chen X; Chen X; Cheng Z; Cui D; Du J; Dullin C; Escudero A; Feliu N; Gao M; George M; Gogotsi Y; Grünweller A; Gu Z; Halas NJ; Hampp N; Hartmann RK; Hersam MC; Hunziker P; Jian J; Jiang X; Jungebluth P; Kadhiresan P; Kataoka K; Khademhosseini A; Kopeček J; Kotov NA; Krug HF; Lee DS; Lehr CM; Leong KW; Liang XJ; Ling Lim M; Liz-Marzán LM; Ma X; Macchiarini P; Meng H; Möhwald H; Mulvaney P; Nel AE; Nie S; Nordlander P; Okano T; Oliveira J; Park TH; Penner RM; Prato M; Puntes V; Rotello VM; Samarakoon A; Schaak RE; Shen Y; Sjöqvist S; Skirtach AG; Soliman MG; Stevens MM; Sung HW; Tang BZ; Tietze R; Udugama BN; VanEpps JS; Weil T; Weiss PS; Willner I; Wu Y; Yang L; Yue Z; Zhang Q; Zhang Q; Zhang XE; Zhao Y; Zhou X; Parak WJ
ACS Nano; 2017 Mar; 11(3):2313-2381. PubMed ID: 28290206
[TBL] [Abstract][Full Text] [Related]
2. Nano based drug delivery systems: recent developments and future prospects.
Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J
Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591
[TBL] [Abstract][Full Text] [Related]
4. Peptides as targeting elements and tissue penetration devices for nanoparticles.
Ruoslahti E
Adv Mater; 2012 Jul; 24(28):3747-56. PubMed ID: 22550056
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
[TBL] [Abstract][Full Text] [Related]
6. Cellular and Molecular Targeted Drug Delivery: Nanochemistry in Medical Theranostics.
Yadollahpour A
Curr Top Med Chem; 2020; 20(27):2425-2426. PubMed ID: 33210582
[No Abstract] [Full Text] [Related]
7. Evaluating Nanomedicines: Obstacles and Advancements.
Swierczewska M; Crist RM; McNeil SE
Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles.
Lanza GM; Winter PM; Caruthers SD; Hughes MS; Cyrus T; Marsh JN; Neubauer AM; Partlow KC; Wickline SA
Nanomedicine (Lond); 2006 Oct; 1(3):321-9. PubMed ID: 17716162
[TBL] [Abstract][Full Text] [Related]
9. In Silico Models for Nanomedicine: Recent Developments.
Mascheroni P; Schrefler BA
Curr Med Chem; 2018; 25(34):4192-4207. PubMed ID: 28911299
[TBL] [Abstract][Full Text] [Related]
10. The upcoming field of theranostic nanomedicine: an overview.
Prabhu P; Patravale V
J Biomed Nanotechnol; 2012 Dec; 8(6):859-82. PubMed ID: 23029995
[TBL] [Abstract][Full Text] [Related]
11. A prospective overview of the essential requirements in molecular modeling for nanomedicine design.
Kumar P; Khan RA; Choonara YE; Pillay V
Future Med Chem; 2013 May; 5(8):929-46. PubMed ID: 23682569
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers.
Aghebati-Maleki A; Dolati S; Ahmadi M; Baghbanzhadeh A; Asadi M; Fotouhi A; Yousefi M; Aghebati-Maleki L
J Cell Physiol; 2020 Mar; 235(3):1962-1972. PubMed ID: 31441032
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
[TBL] [Abstract][Full Text] [Related]
14. Polymer-Based Drug Delivery Systems, Development and Pre-Clinical Status.
Jaimes-Aguirre L; Gibbens-Bandala BV; Morales-Avila E; Ocampo-García BE; Seyedeh-Fatemeh M; Amirhosein A
Curr Pharm Des; 2016; 22(19):2886-903. PubMed ID: 26898743
[TBL] [Abstract][Full Text] [Related]
15. Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis.
Beh CY; Prajnamitra RP; Chen LL; Hsieh PC
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443638
[TBL] [Abstract][Full Text] [Related]
16. Metal-Organic Framework-Based Nanomedicine Platforms for Drug Delivery and Molecular Imaging.
Cai W; Chu CC; Liu G; Wáng YX
Small; 2015 Oct; 11(37):4806-22. PubMed ID: 26193176
[TBL] [Abstract][Full Text] [Related]
17. Are existing standard methods suitable for the evaluation of nanomedicines: some case studies.
Gioria S; Caputo F; Urbán P; Maguire CM; Bremer-Hoffmann S; Prina-Mello A; Calzolai L; Mehn D
Nanomedicine (Lond); 2018 Mar; 13(5):539-554. PubMed ID: 29381129
[TBL] [Abstract][Full Text] [Related]
18. Delivering the power of nanomedicine to patients today.
Germain M; Caputo F; Metcalfe S; Tosi G; Spring K; Åslund AKO; Pottier A; Schiffelers R; Ceccaldi A; Schmid R
J Control Release; 2020 Oct; 326():164-171. PubMed ID: 32681950
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
Du JZ; Li HJ; Wang J
Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-Based Modulation of the Immune System.
Fang RH; Zhang L
Annu Rev Chem Biomol Eng; 2016 Jun; 7():305-26. PubMed ID: 27146556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
